Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-26 @ 10:34 AM
Ignite Modification Date: 2025-12-26 @ 10:34 AM
NCT ID: NCT00770328
Description: None
Frequency Threshold: 5
Time Frame: The subjects were followed from baseline to 8 weeks.
Study: NCT00770328
Study Brief: The Effects of Pentoxifylline on PAI-1 in an Obese Population
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Pentoxifylline Patients receive Pentoxifylline 400 mg po TID for 8 weeks. Pentoxifylline: 400mg PO TID x 8 weeks None None 0 22 11 22 View
Placebo Patients take a placebo TID for 8 weeks. Placebo: PO TID x 8 weeks None None 0 15 2 15 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Nausea/Vomiting SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View
Allergic Reaction SYSTEMATIC_ASSESSMENT Immune system disorders None View
Bloating SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View